Volume to Value: TriCore Shares Reimbursement Strategies at September Webinar


ALBUQUERQUE, N.M., Sept. 21, 2015 (GLOBE NEWSWIRE) -- There is a new reality in healthcare and lab testing: payers are less willing to pay fee-for-service. TriCore's new strategic direction is driven in large part by a healthcare market becoming more focused on outcomes and value. Federal and private payers increasingly are shifting payment models from ones based on fee-for-service and volumes to reimbursement models tied to accountability and outcomes.

"We believe that the clinical laboratory has a responsibility and the ability to reshape healthcare delivery," said Khosrow Shotorbani, President & CEO of TriCore Reference Laboratories. "Laboratories must transition their value statements to stay relevant in today's landscape. For us that means staying true to our core competencies as a laboratory, while preparing for the changes we know are coming for our industry."

"These are the reasons why a handful of progressive labs in the United States have already stepped up with strategies that increase the value of their lab testing services," says Robert L. Michel, Editor-in-Chief of The Dark Report. On Tuesday, September 22, 2015 at 1:00 PM EDT, clinical laboratory professionals will have the opportunity to engage with two visionary lab leaders and gain crucial information about this topic during a new webinar, entitled "Moving from Volume-Based to Value-Based: New Business Models in the Clinical Laboratory Industry."
 
"During this timely and important session, webinar participants will learn what is working, why it is working, and how laboratories can benefit from developing value-based lab testing services,'" continued Michel. "Participants will benefit from hearing about the lessons these lab leaders have learned, as well as the most effective and efficient ways for lab teams to consult with clinicians in order to help them improve their patients' outcomes."

Khosrow R. Shotorbani, MBA, MT(ASCP) and Richard J. Cote, M.D.,Chair, Department of Pathology, University of Miami Miller School of Medicine will host the webinar. Mr. Shotorbani will explain how TriCore is delivering "big data"-based clinical services to physicians that enable them to achieve measurably better patient outcomes. Dr. Cote will discuss how his pathology department and clinical laboratory have reacted to the highly competitive healthcare market with multiple service enhancements.

Among the valuable information to be presented during this 90-minute webinar:

Reassessing how laboratory services should be delivered, and how to best provide value to the health care system

Defining the value proposition beyond pricing and incorporating non-commodity drivers of value

Examples of value-added clinical services that pathology and clinical laboratories can provide to meet the market demand

How other pathology/clinical lab groups have realigned their financial strategies to meet the changes of the new payment system

Because information is a key value driver, the session will cover the inclusion of informatics as a part of the retooling

How to be a collaborative partner with integrated delivery systems, ACOs, medical homes, and health insurers

Tips for moving confidently forward with leveraging the lab's competencies, and much more!

As an extra value-added benefit of this webinar, the end of the session will be opened up for a live Q &A. For more information about "Moving from Volume-Based to Value-Based: New Business Models in the Clinical Laboratory Industry" and to view webinar details including presenter biographies and pricing, visit tinyurl.com/volume2value. You may also contact Ron Martin at 512-264-7103.

About TriCore Reference Laboratories


TriCore Reference Laboratories provides the majority of clinical diagnostic testing for New Mexico and offers solutions and services in population health management and targeted intervention strategies. TriCore has emerged as a leader in reference laboratory services, performing a full range of tests – from the routine to the highly esoteric under the direction of more than 30 pathologists and scientific directors. For more information visit www.tricore.org

About THE DARK REPORT


Established in 1995, THE DARK REPORT is the leading source of exclusive business intelligence for laboratory CEOs, COOs, CFOs, Pathologists and Senior industry executives. It is widely read by leaders in laboratory medicine and diagnostics. The Dark Report produces the famous Executive War College on Laboratory and Pathology Management every spring, which showcases innovations by the nation's and globe's leading laboratory organizations. Dark Daily is an Internet-based e-briefing intelligence service, read worldwide by thought leaders in laboratory and pathology management. Other well-known conferences conducted by THE DARK REPORT are Lab Quality Confab (on the use of Lean and Six Sigma methods in labs and hospitals) and Molecular Summit (on the integration of in vivo and in vitro diagnostics). THE DARK REPORT co-produces Frontiers in Laboratory Medicine annually in the United Kingdom; Executive Edge bi-annually in Canada; and The Business of Pathology bi-annually in Australia.
 


            

Contact Data